351 related articles for article (PubMed ID: 27900619)
21. Renin angiotensin system inhibition in the older person: a review.
Mohamed MA; Weir MR
Clin Geriatr Med; 2009 May; 25(2):245-57. PubMed ID: 19555871
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of antihypertensive treatment based on plasma renin activity: An open label observational study.
Leotta G; Rabbia F; Testa E; Totaro S; Abram S; Milan A; Mulatero P; Veglio F
Blood Press; 2010 Aug; 19(4):218-24. PubMed ID: 20367559
[TBL] [Abstract][Full Text] [Related]
23. Renin inhibition--benefit beyond hypertension control.
Kher V
J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
[TBL] [Abstract][Full Text] [Related]
24. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
25. Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?
Chen SS; Seliger SL; Fried LF
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):449-55. PubMed ID: 25014549
[TBL] [Abstract][Full Text] [Related]
26. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
Minami J; Ishimitsu T; Matsuoka H
Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
[No Abstract] [Full Text] [Related]
27. Aliskiren, the future of renin-angiotensin system blockade?
Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
[TBL] [Abstract][Full Text] [Related]
28. [Blood pressure independent effects of antihypertensive agents].
Wenzel U; Wolf G
Internist (Berl); 2005 May; 46(5):548-56. PubMed ID: 15800776
[TBL] [Abstract][Full Text] [Related]
29. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
30. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
Neutel JM
J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
[TBL] [Abstract][Full Text] [Related]
31. Novel drugs targeting hypertension: renin inhibitors and beyond.
Leibovitz E; Schiffrin EL
J Cardiovasc Pharmacol; 2007 Jul; 50(1):3-8. PubMed ID: 17666909
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular benefits of probiotics: a review of experimental and clinical studies.
Thushara RM; Gangadaran S; Solati Z; Moghadasian MH
Food Funct; 2016 Feb; 7(2):632-42. PubMed ID: 26786971
[TBL] [Abstract][Full Text] [Related]
33. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
Cicero AF; Gerocarni B; Rosticci M; Borghi C
Clin Exp Hypertens; 2012; 34(2):113-7. PubMed ID: 21967031
[TBL] [Abstract][Full Text] [Related]
34. Role of the renin-angiotensin system in hypertension in the elderly.
Nagano M; Higaki J; Mikami H; Ogihara T
Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic possibilities for the inhibition of the renin-angiotensin-aldosterone system].
Abrahám G; Légrády P
Orv Hetil; 2003 May; 144(18 Suppl 1):892-5. PubMed ID: 12785232
[TBL] [Abstract][Full Text] [Related]
36. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.
Soldner A; Spahn-Langguth H; Mutschler E
Pharmazie; 1996 Nov; 51(11):783-99. PubMed ID: 8985974
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies.
Kang Y; Cai Y
Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):110-117. PubMed ID: 29102544
[TBL] [Abstract][Full Text] [Related]
38. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients.
Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H
Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-(1-7) as a strategy in the treatment of hypertension?
van Twist DJ; Kroon AA; de Leeuw PW
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):480-6. PubMed ID: 25023950
[TBL] [Abstract][Full Text] [Related]
40. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
Tempelhof MW
South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
